The Radiotherapy Positioning Devices Market is estimated to be valued at USD 1031.8 million in 2025 and is projected to reach USD 1830.4 million by 2035, registering a compound annual growth rate (CAGR) of 5.9% over the forecast period.
| Metric | Value |
|---|---|
| Radiotherapy Positioning Devices Market Estimated Value in (2025 E) | USD 1031.8 million |
| Radiotherapy Positioning Devices Market Forecast Value in (2035 F) | USD 1830.4 million |
| Forecast CAGR (2025 to 2035) | 5.9% |
The Radiotherapy Positioning Devices market is experiencing consistent growth, driven by the increasing prevalence of cancer and the rising adoption of precision radiotherapy techniques. The demand for accurate patient positioning systems is being supported by the need to enhance treatment efficacy, minimize radiation exposure to healthy tissues, and improve overall patient outcomes. Advanced devices integrating immobilization, motion management, and real-time monitoring capabilities are improving treatment accuracy and efficiency.
Technological innovations in device ergonomics, material composition, and compatibility with imaging and radiotherapy equipment are further fueling adoption. Hospitals and cancer treatment centers are increasingly investing in positioning systems to support high-precision therapies such as intensity-modulated radiotherapy and stereotactic radiosurgery.
Regulatory emphasis on patient safety, standardized treatment protocols, and compliance with medical device quality standards is reinforcing market expansion As the global oncology burden continues to rise, the Radiotherapy Positioning Devices market is expected to grow steadily, with ongoing innovations and increasing clinical adoption driving both revenue and operational effectiveness across healthcare settings.
The radiotherapy positioning devices market is segmented by product type, end user, and geographic regions. By product type, radiotherapy positioning devices market is divided into Head, Neck And Brain Immobilization Device, Thorax And Breast Immobilization Device, Pelvic Immobilization Devices, and Others. In terms of end user, radiotherapy positioning devices market is classified into Hospitals, Ambulatory Surgical Centers, Cancer Research Institutes, and Others. Regionally, the radiotherapy positioning devices industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The head, neck and brain immobilization device segment is projected to hold 38.7% of the market revenue in 2025, making it the leading product type. Growth in this segment is being driven by the critical need for precise immobilization during radiotherapy for cranial, cervical, and brain cancers. These devices enable stable patient positioning, minimizing movement and improving treatment accuracy while protecting surrounding healthy tissues from radiation exposure.
Advanced materials and design enhancements provide patient comfort, facilitate imaging compatibility, and support repeated use across multiple treatment sessions. Adoption is further reinforced by the increasing prevalence of brain and head-and-neck cancers and the rising demand for advanced radiotherapy procedures that require exact positioning.
Hospitals and specialized oncology centers are leveraging these devices to ensure treatment precision, optimize clinical outcomes, and maintain compliance with safety standards Continuous innovation in device ergonomics, imaging integration, and workflow efficiency is expected to sustain the leading position of this segment.
The hospitals end-use segment is expected to account for 42.5% of the market revenue in 2025, establishing it as the leading end-user category. Its growth is being driven by the rising number of oncology centers and the increasing adoption of advanced radiotherapy systems within hospital settings. Hospitals require precise and reliable positioning devices to ensure treatment accuracy, reduce radiation-related complications, and enhance patient safety.
Integration of immobilization devices with imaging systems and treatment planning software allows for real-time monitoring, improved workflow efficiency, and optimized patient throughput. The segment is further supported by ongoing investments in healthcare infrastructure, modern cancer treatment facilities, and high-precision radiotherapy technologies.
Training and adoption of standardized protocols for device usage in hospitals improve clinical outcomes and treatment reproducibility As cancer treatment volumes continue to rise globally and hospitals prioritize precision radiotherapy, the end-use segment is expected to remain the primary revenue contributor, supported by operational efficiency, technological integration, and patient-centric care strategies.
The Radiotherapy positioning devices are used to position the patients during radiotherapy session. The patient positioning and immobilization are important during the radiation therapy treatment. The radiotherapy positioning devices are manufactured by the company understanding the need of the radiotherapy specialist and comfort of the patient.
The devices ensure ideal comfort and precision to the patient during therapy sessions. Cancer is a leading cause of death worldwide and is projected to rise with an estimated 11.5 million deaths in 2035. Cancer can be treated with surgery, chemotherapy, radiation therapy, hormone therapy, targeted therapy, precision medicine, immunotherapy and stem cell transplantation. Several clinical trials are ongoing to establish the potential of radiolabelled monoclonal antibody.
Radiotherapy is also used to treat patients suffering from non-Hodgkin B-cell lymphoma, and other sub-types of lymphoma or patients who do not respond to chemotherapy. Generally, no side effects are seen during the treatment. To ensure the efficient treatment process via radiotherapy, the comprehensive range of positioning radiotherapy devices are marketed across the globe
The radiotherapy positioning device manufacturers are aiming to improve the outcomes of the patient and healthcare specialist globally to provide high quality, unique and innovative patient-centric radiotherapy positioning devices. The patient positioning devices are accurate and provide maximum repositioning accuracy and patient stability by reducing both voluntary and involuntary patient movement.
Increasing discretionary funding for cancer research by government and federal agencies, increase in Medicare coverage, rising prevalence of cancer among growing population, availability of new cancer treatment, and other devices accessory for the patients during the treatment process are some of the factors boosting the radiotherapy positioning devices market.
| Country | CAGR |
|---|---|
| China | 8.0% |
| India | 7.4% |
| Germany | 6.8% |
| Brazil | 6.2% |
| USA | 5.6% |
| UK | 5.0% |
| Japan | 4.4% |
The Radiotherapy Positioning Devices Market is expected to register a CAGR of 5.9% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 8.0%, followed by India at 7.4%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates. Japan posts the lowest CAGR at 4.4%, yet still underscores a broadly positive trajectory for the global Radiotherapy Positioning Devices Market. In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 6.8%. The USA Radiotherapy Positioning Devices Market is estimated to be valued at USD 369.9 million in 2025 and is anticipated to reach a valuation of USD 369.9 million by 2035. Sales are projected to rise at a CAGR of 0.0% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 51.5 million and USD 28.6 million respectively in 2025.
| Item | Value |
|---|---|
| Quantitative Units | USD 1031.8 Million |
| Product Type | Head, Neck And Brain Immobilization Device, Thorax And Breast Immobilization Device, Pelvic Immobilization Devices, and Others |
| End User | Hospitals, Ambulatory Surgical Centers, Cancer Research Institutes, and Others |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
| Country Covered | United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa |
| Key Companies Profiled | Varian Medical Systems, Elekta AB, CIVCO Radiotherapy, Brainlab AG, Accuray Incorporated, IBA Dosimetry GmbH, Qfix, Orfit Industries, Medtronic plc, Stryker Corporation, Smith & Nephew plc, Bionix Radiation Therapy, C-RAD AB, Klarity Medical Products, and Mizuho OSI |
The global radiotherapy positioning devices market is estimated to be valued at USD 1,031.8 million in 2025.
The market size for the radiotherapy positioning devices market is projected to reach USD 1,830.4 million by 2035.
The radiotherapy positioning devices market is expected to grow at a 5.9% CAGR between 2025 and 2035.
The key product types in radiotherapy positioning devices market are head, neck and brain immobilization device, thorax and breast immobilization device, pelvic immobilization devices and others.
In terms of end user, hospitals segment to command 42.5% share in the radiotherapy positioning devices market in 2025.
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Radiotherapy Device Market is segmented by External Beam Radiation Therapy Device and Internal Beam Radiation Therapy Device from 2025 to 2035
Radiotherapy-Induced Oral Mucositis Treatment Market Analysis – Growth & Forecast 2024-2034
Radiotherapy Motion Management Market
Radiotherapy Patient Positioning Accessories Market Trends – Forecast 2025 to 2035
Europe Radiotherapy Patient Positioning Market Size and Share Forecast Outlook 2025 to 2035
Single Dose Radiotherapy Services Market – Growth & Forecast 2025 to 2035
Single Dose Radiotherapy Market
Image Guided Radiotherapy Market Size and Share Forecast Outlook 2025 to 2035
Automated Contouring Radiotherapy Software Market
Repositioning and Offloading Market – Trends & Forecast 2024 to 2034
Repositioning & Offloading Devices Market – Demand & Forecast 2024 to 2034
X-Ray Positioning Devices Market Size and Share Forecast Outlook 2025 to 2035
Spine Positioning Devices Market
Infant Positioning Aids Market Size and Share Forecast Outlook 2025 to 2035
Global Positioning Systems Market Size and Share Forecast Outlook 2025 to 2035
Dynamic Positioning System Market Size and Share Forecast Outlook 2025 to 2035
Patient Positioning Equipment Market Size and Share Forecast Outlook 2025 to 2035
Patient Positioning System Analysis by Product Type and by End User through 2035
Seating And Positioning Belts Market Size and Share Forecast Outlook 2025 to 2035
Assured PNT (Positioning, Navigation, and Timing) Market Size and Share Forecast Outlook 2025 to 2035
Radiotherapy Positioning Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
